Method for treating a pulmonary hypertension condition
US9993475B2 · kind B2 · utility
0Cited by
13References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 23, 2016 |
| Grant date | Jun 12, 2018 |
| Priority date | — |
| Expiry date | Nov 23, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating a pulmonary hypertension condition such as pulmonary arterial hypertension (PAH) in a subject comprises administering to the subject a therapeutically effective amount of ambrisentan, wherein, at baseline, time from first diagnosis of the condition in the subject is not greater than about 2 years.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.